You searched for FDA - Page 5 of 34

Prepared Monkfish Liver (Ankimobo) Photo Source :Mutual trading

Health

Monkfish Liver Recalled in Five States for Undeclared Milk Allergen, FDA Warns Allergy Risks.

New York Mutual Trading Co. has recalled its Prepared Monkfish Liver from stores and restaurants across five states after discovering it contains undeclared milk ingredients. For someone with milk allergies, it could

Tejal Somvanshi

January 17, 2025

Representative Image. Grayscale Photo of Eggs on a Tray. Photo Source: Renato K. (Pexels)

Health·News·USA

FDA Elevates Costco Egg Recall to Highest Risk Level Over Salmonella Concerns

The U.S. Food and Drug Administration (FDA) has upgraded the Costco egg recall to Class I – its highest risk classification. The recall, initiated by Handsome Brook Farms on November 27, 2024,

Tejal Somvanshi

December 25, 2024

Representative Image. Woman Sleeping. Photo Source: Ivan Obeleninov (Pexels)

Health·News·USA

FDA Approves Zepbound: First Sleep Apnea Drug Reduces Breathing Events by 25/hour, 18% Weight Loss

The U.S. Food and Drug Administration (FDA) has approved Zepbound (tirzepatide), marking the first medication authorized for treating moderate to severe obstructive sleep apnea (OSA) in adults with obesity. The approval comes

Tejal Somvanshi

December 24, 2024

Representative Image. A Person Holding his Belly Fat. Photo Source: Towfiqu barbhuiya (Pexels)

Health

FDA Ends Tirzepatide Shortage, Orders Compounded Versions Phased Out by March 2024

The Food and Drug Administration (FDA) confirmed Thursday that Eli Lilly’s tirzepatide-based medications, Zepbound and Mounjaro, are no longer in shortage. This decision requires compounding pharmacies to cease production of alternative versions

Tejal Somvanshi

December 21, 2024

Representative Image. A dog having the medical check-up. Photo Source: Gustavo Fring (Pexels)

Health·News·USA

FDA Warns: Librela Linked to 3,600+ Adverse Reactions, Including Seizures and Deaths in Dogs

The Food and Drug Administration’s Center for Veterinary Medicine has issued an urgent warning about Librela, a widely-used injectable medication for dogs with osteoarthritis, following reports of severe adverse effects including deaths.

Tejal Somvanshi

December 21, 2024

A confident man in a suit delivers a speech at a podium, with a bright blue background.

Health·News·USA

RFK Jr.’s Lawyer Petitioned FDA to Revoke Polio Vaccine Approval

Aaron Siri, a lawyer helping Robert F. Kennedy Jr., has filed petitions seeking to revoke FDA approval of the polio vaccine and suspend distribution of 13 other vaccines. This development comes as

Tejal Somvanshi

December 18, 2024

Health·USA

FDA Recalls 7,107 Duloxetine Bottles Due to Cancer-Linked N-Nitroso Contamination Risk

Rising Pharmaceuticals has initiated a nationwide recall of 7,107 bottles of duloxetine after discovering contamination with N-nitroso-duloxetine, a chemical compound linked to cancer risks. The recall, classified as Class II by the

Tejal Somvanshi

December 13, 2024

Health·USA

FDA Battles Supreme Court Over Flavored Vape Ban Amid 1.6 Million Teen Users Crisis

The Supreme Court faces a pivotal decision as it prepares to hear arguments on whether to reinstate the FDA’s ban on sweet-flavored vaping products. The case follows what Trump’s own FDA commissioner

Tejal Somvanshi

November 29, 2024

Health·News·USA

FDA Egg Recall Update: Salmonella Outbreak Grows as Over 345,000 Dozen Eggs Pulled Amid Class I Health Risk

The Food and Drug Administration (FDA) has recently upgraded a previous egg recall alert, cautioning consumers about potential severe reactions and even death if the affected products are consumed. This development marks

Tejal Somvanshi

October 8, 2024

Health·News·USA

Lunds & Byerlys Recalls 500 Lone Star Dip Containers: FDA Alerts Mold Risk, Affects Twin Cities Store

To prioritize consumer safety, the upscale Minnesota supermarket chain Lunds & Byerlys has voluntarily recalled approximately 500 containers of its popular Lone Star Dip. The recall, announced by the Food and Drug

Tejal Somvanshi

October 8, 2024